FDA Panel Says ‘No’ to Weight Loss Drug Qnexa

Published July 16, 2010

FDA Panel Says ‘No’ to Weight Loss Drug Qnexa
An FDA advisory panel voted against approval of the weight loss drug Qnexa because of potential side effects.
Read more on WebMD

Adolor to cut 30 jobs as Entereg sales disappoint
Drug maker Adolor Corp. said Thursday it is eliminating 30 jobs, or more than a quarter of its work force, as sales of its drug Entereg did not meet its expectations.
Read more on AP via Yahoo! Finance

Criminalization Of Drugs And Drug Users Fuels HIV; Laws Should Be Reviewed
Policy resistance to harm reduction for drug users and potential effect of changeStrict laws on the criminalisation of drug use and drug users are fuelling the spread of HIV and other serious harms associated with the criminal market and should be reviewed, say experts in a series of articles published on bmj.com today to coincide with the 18th International AIDS Conference in Vienna, 18-23 July …
Read more on redOrbit